SPRY - ARS Pharmaceuticals, Inc.
IEX Last Trade
11.1
0.020 0.180%
Share volume: 37,468
Last Updated: Thu 26 Dec 2024 08:30:19 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$11.08
0.02
0.18%
Summary score
24%
Profitability
25%
Dept financing
1%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-5.01%
Return on assets
-5.31%
Return on sales
-99165.94%
Return on invested capital
76.97%
Total debt ratio
3.9%
Debt ratio change over timeo
-1.02%
Current Ratio
37.37%
Quick Ratio
37.37%
Cash Position Ratio
36.84%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5.24%
Return on assets
-6.34%
Return on sales
-206030%
Return on invested capital
422.28%
Total debt ratio
2.79%
Debt ratio change over timeo
-0.99%
Current Ratio
51.26%
Quick Ratio
51.26%
Cash Position Ratio
50.61%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-4.6%
Return on assets
-5.8%
Return on sales
0%
Return on invested capital
433.71%
Total debt ratio
1.63%
Debt ratio change over time
-1%
Current Ratio
60.9%
Quick Ratio
60.9%
Cash Position Ratio
60.2%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-97.13%
Return on assets
-97.45%
Return on sales
-39377.51%
Return on invested capital
-102.38%
Total debt ratio
-102.02%
Debt ratio change over time
-1.02%
Current Ratio
-3.12%
Quick Ratio
-3.12%
Cash Position Ratio
-3.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SPRY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.01% | 13.79% | 34.47% | 7.43% |
| Return on assets | -5.31% | 2.76% | 3.15% | 5.62% |
| Return on sales | -99165.94% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 76.97% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 61% | 62% |
| Total debt ratio | 3.9% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.02% | 308.97% | -6.99% | 1.18% |
| Dept financing | 1% | 50% | 25% | 7% |
| Current Ratio | 51.26% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 51.26% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 50.61% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 1% | 3% | 7% |
| Short-term ratios | SPRY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.24% | 13.77% | 13.25% | 3.8% |
| Return on assets | -6.34% | 2.43% | 1.89% | 3.09% |
| Return on sales | -206030% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 422.28% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 57% |
| Total debt ratio | 2.79% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.99% | 46.38% | -72.08% | 1.51% |
| Dept financing | 1% | 50% | 25% | 7% |
| Current Ratio | 51.26% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 51.26% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 50.61% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 1% | 3% | 6% |